At Novartis, we want to build an exciting workplace in which people can realize their professional ambitions. We believe we can do this by creating a motivating environment where creativity and effectiveness are encouraged and where leading technologies are applied. The stories collected here will introduce you to Novartis and to some of the people who represent how we work.
John Telford is a research director and project leader in the research unit at Novartis Vaccines. John began his career as a staff scientist at the Sclavo Research Center in 1985 and has stayed with the company through mergers with Chiron and eventually Novartis in 2006. We sat down to talk with John about his research and his thoughts on Novartis Vaccines.
About Novartis Vaccines
Novartis Vaccines is the world's fifth-largest vaccines business.
Fighting against meningitidis by finding novel treatments is one of Novartis Vaccines priority.